Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Steatorrhea - Wikipedia

   en.wikipedia.org/wiki/Steatorrhea

   Steatorrhea. Steatorrhea. Specialty. Gastroenterology, general surgery. Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult to flush, have a pale and oily appearance, and can be especially foul-smelling. [ 1] An oily anal leakage or some level of fecal incontinence may occur.

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

5. What Is the Strongest Weight Loss Prescription Pill? - AOL

   www.aol.com/strongest-weight-loss-prescription...

   Orlistat (Xenical, Alli). Orlistat works by preventing your body from absorbing dietary fats. It inhibits lipase, an enzyme in the intestine that breaks down fat molecules. This leads to reduced ...

6. Eli Lilly vs Novo Nordisk: A Recent Study Suggests This ... - AOL

   www.aol.com/eli-lilly-vs-novo-nordisk-102000044.html

   In clinical trials, tirzepatide has demonstrated some truly incredible numbers. Last year, Eli Lilly reported that in an 84-week study, patients were able to lose up to 26.6% of their body weight ...

7. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Pfizer announced on Dec. 1 that it was discontinuing phase 3 clinical trials of the twice-daily version due to high rates of adverse side effects. While these were mostly mild, a large percentage ...